The recessive model of MRP2 G1249A polymorphism decrease the risk of drug-resistant in Asian Epilepsy: a systematic review and meta-analysis

Epilepsy Res. 2015 May:112:56-63. doi: 10.1016/j.eplepsyres.2015.02.007. Epub 2015 Feb 16.

Abstract

ABCC2 gene polymorphisms have been shown to be associated with drug-resistant epilepsy. However, the published results were controversial. To comprehensively re-evaluate the association between ABCC2 gene polymorphisms and drug-resistant epilepsy in Asian, we carried out this meta-analysis, which included eight related studies. Studies were selected using PUBMED, Web of science, the Cochrane database of system reviews and Embase. Pooled odds ratio (OR) with 95% confidence interval (CI) was used to assess the association. Studies with 1302 drug-resistant cases and 1563 drug-sensitive controls were included. No significant association was detected by combined analyses for C-24T, G-1774delG, C3972T and G2934A. However, significant association was found in recessive model for G1249A polymorphism (GG vs. GA+AA: OR=0.72, 95%CI=0.53-0.96, P=0.03), indicating the recessive model of G1249A in MRP2/ABCC2 might decrease the risk of drug resistance in Asian epilepsy.

Keywords: ABCC2; Asian; Drug-resistance; Epilepsy; Meta-analysis.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Anticonvulsants / therapeutic use
  • Asia
  • Drug Resistance / genetics
  • Epilepsy / drug therapy
  • Epilepsy / genetics*
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins / genetics*
  • Polymorphism, Single Nucleotide / genetics*

Substances

  • ABCC2 protein, human
  • Anticonvulsants
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins